Search Results - shuying+sun

1 Results Sort By:
Method to Inhibit Toxic Pathways Activated in Genetic ALS/FTD
Value PropositionTreatment readily acts via subcutaneous injection and crosses the blood-brain barrier without extra formulation or drug delivery mechanism.Treatment significantly reduces pathological and behavioral phenotypes from toxic proteins coded by genetic defects in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), which...
Published: 3/14/2025   |   Inventor(s): Shuying Sun, Zhe Zhang
Keywords(s):  
Category(s): Clinical and Disease Specializations > Neurology, Clinical and Disease Specializations > Neurology > Amyotrophic Lateral Sclerosis, Clinical and Disease Specializations > Neurology > Neurodegeneration, Clinical and Disease Specializations > Neurology > Motor Neuron Diseases, Clinical and Disease Specializations > Neurology > Dementia, Technology Classifications > Therapeutic Modalities > Peptides, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics > Biomarkers
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum